READ. SCROLL. LISTEN.

Unbiased headlines. Facts, not spin.

Unbiased Headlines is an independently owned news organization. We bring you the facts, not opinions, written fresh from 110+ named sources. Sources linked so you can verify it yourself.

← Back to headlines

Anthropic IPO Pricing Set for Nov. 18 as Morningstar Calls $70-$78 Range Undervalued

Anthropic IPO Pricing Set for Nov. 18 as Morningstar Calls $70-$78 Range Undervalued
Morningstar puts Anthropic's fair value at $92 a share, 24% above the $74 midpoint of its IPO range, while the company's own filing warns of "catastrophic or existential risks to humanity." Pricing is expected Nov. 18, and the self-improving-AI claims in the prospectus are now part of what investors are being asked to value.

Anthropic's IPO is expected to price on Nov. 18 at a range of $70 to $78 per share. Morningstar says that is too low. The research firm puts fair value at $92 a share, or $1.7 trillion in equity value.

Against the $74 midpoint, that is 24% upside, according to Morningstar's estimate. The top of the range values Anthropic at up to $1.4 trillion on a fully diluted basis. The company eyed $2 trillion back in September.

Morningstar's range of outcomes

Morningstar attributes the lower range to the market, not the business. In its view, the deal is being priced during a stretch of high volatility, with investors increasingly souring on the AI trade.

Its bull case assumes rapid adoption of Claude and material share gains against rivals such as OpenAI. That yields a fair value of $188, more than 150% above the midpoint.

Its bear case assumes slower enterprise adoption and robust competition from open-weight model providers. That yields $25, a 66% drop from the midpoint.

A spread of $25 to $188 is not a narrow call. Morningstar itself says the self-improvement scenario "further widens the range of outcomes in both directions."

Self-improving AI is now part of the pitch

Anthropic's IPO documents make recursive self-improvement, AI helping to build better AI, a stated part of the investment case.

Morningstar cites three markers. Claude now writes more than 90% of contributions to Anthropic's codebase. Claude leads around a quarter of the company's model research tasks, up from about 1% in March. And the amended prospectus says internal estimates indicate Anthropic may soon meet its own threshold for accelerated, AI-driven progress.

Morningstar also points to METR, a safety-focused third-party group that reviewed Anthropic's internal data. This month METR estimated that Anthropic's pace of AI progress has roughly doubled over the past year, attributing loosely 80% of that acceleration to AI itself.

Morningstar acknowledges that investors may dismiss the claims as dubious or overblown. It says outside AI researchers are taking them seriously, and it cites their view that AI could begin outperforming Anthropic's best human researchers sometime in 2027.

What the filing says could go wrong

The original S-1, registered on a Monday in late October, runs 335 pages. Nearly a third is devoted to risk, according to CBS News' review of the document.

Anthropic writes that its technology could pose "catastrophic or existential risks to humanity." It says models could "resist shutdown" and even engage in "blackmail" to persuade humans to "preserve the model's continued operation or access."

The filing also says models could take actions counter to a user's intent, such as gaining access to third-party systems. It warns that bad actors could use the models to develop weapons or conduct cyberattacks.

On self-improvement, the filing warns that models could replicate flaws or errors in future models, something that would be "difficult to detect or remediate." The company warned earlier this year that the capability, which AI does not yet have, could arrive sooner than people are ready for.

Routine disclosure or real tension

Jay Ritter, an IPO expert at the University of Florida's Warrington College of Business, notes that companies going public commonly disclose a sprawling set of risks.

David Hsu, a professor at the University of Pennsylvania's Wharton School, sees something different. "The company is asking investors to fund a race to more autonomous AI while acknowledging that capability could outpace safety," he said in an email. "This is not an ordinary technology risk. It is a governance issue with potentially societal consequences."

The tension is built into the valuation. A business expected to top $1 trillion depends on the continued spread of a technology that its own developers say could cause worldwide harm.

What to watch

The $70 to $78 range is an offer range, not a market price, and pricing is expected on Nov. 18.

It is unclear where the deal will price. Morningstar's $92 fair value sits above the top of the range. Whether buyers agree with that, or with its $25 bear case, will start to show once the shares trade.

Sources used for this briefing

2 links from 2 independent newsrooms (syndicated copies of the same report count once)

These are the sources it draws on, linked so you can verify.

center-left
CBS NewsAnthropic's IPO filing lists 93 pages of risks. What could possibly go wrong?
unknown
MorningstarAnthropic: We See the Stock as Undervalued in the IPO Pricing Range